期刊文献+

葡萄糖对大鼠骨髓破骨细胞骨吸收功能的影响 被引量:2

Effect of glucose on bone resorption by osteoclasts derived from rat bone marrow cells
原文传递
导出
摘要 目的观察葡萄糖对大鼠骨髓破骨细胞骨吸收功能的影响,探讨糖尿病骨质疏松的发病机制。方法用巨噬细胞集落刺激因子、RANKL诱导大鼠骨髓单个核细胞分化为破骨细胞,同时给予不同浓度的葡萄糖(0、5.5、15、25mmol/L)干预,通过观察骨吸收陷窝数量和面积比及破骨细胞膜表面整合素ανβ3(CD61)表达水平分析葡萄糖对破骨细胞骨吸收功能的影响,结果(1)高糖(25mmol/L)组培养7d骨吸收陷窝数量和面积比与其他3组相比明显增多(P〈0.05或P〈0.01)。(2)高糖组破骨细胞膜表面CD61表达量及平均荧光强度3d时与其他3组相比均明显上调(P〈0.05或P〈0.01);5、7d时与对照组(0mmol/L)相比明显上调(P〈0.05)。结论高糖可增强破骨细胞的骨吸收功能,这可能是糖尿病骨质疏松的发病机制之一。 Objective To observe the effect of glucose on bone resorption by osteoclasts derived from rat bone marrow cells, and to study the role of glucose in the pathogenesis of diabetic osteoporosis. Methods Mononuclear cells from rat bone marrow were incubated with α-MEM containing macrophage colony stimulating factor(M-CSF) and receptor activator of NF-κB ligand( RANKL). The culture was treated with glucose of different concentrations(0,5.5,15,25 mmol/L). The effect of glucose on bone resorption by osteoclast was studied by analyzing absorptive lacuna and the expression of integrin ανβ3 ( CD61 ). Results ( 1 ) The amount and area ratio of bone absorptive lacuna in high glucose(25 mmol/L)group showed significant difference from the other 3 groups at day 7 (P〈0.05 or P〈0.01 ). (2)The expression of CD61 in osteoclast were up-regulated in high glucose group compared with the other 3 groups at day3 (P〈0.05 or P〈0.01 ),and showed signifcant difference with the control (0 mmol/L)group at day 5and 7 (P〈 0. 05 ). Conclusion High glucose may enhance bone resorption by osteoclasts,suggesting that this may be one of the key pathogenetic factors of diabetic osteoporosis.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2009年第5期549-551,共3页 Chinese Journal of Endocrinology and Metabolism
关键词 葡萄糖 破骨细胞 骨吸收 糖尿病骨质疏松 Glucose Osteoclast Bone resorption Diabetic osteoporosis
  • 相关文献

参考文献12

  • 1蔡德鸿,陈宏,张桦,郭楚霞,王梅.糖基化终末产物对破骨细胞骨吸收功能的影响[J].中华内分泌代谢杂志,2003,19(1):57-59. 被引量:13
  • 2Arnett TR,Dempater DW.A comparative study of disaggregted chick and rat osteoclastin vitro:effects of calcitonin and prostaglandins.Endocrinology,1987,120:602-608.
  • 3Taraesek JJ,Mevers SW,Basmger JB,et al.Diabetic and age-related enhancemen of collagen-lunked flnorescence in cortical bones of rats.Life Sci,1994,55:855-861.
  • 4Antonto JJ.Effects of advanced glycation end-preducts on the proliferation and differentiation of osteoblast-like cells.Mol Cell Biochem,1997,170:43-45.
  • 5Mryata T,Kaketomi S.Possible involvement of advanced glycation endproducts in bone resorption.Ncphrol Dial Transplant,1996,11(Supp5):54-57.
  • 6Takgi M,Kasayarna S,Yamarnoto T,et al.Advanced glycation endproducts stimulate interleukin-6 production by human bone-derived cells.J Bone Miner Res,1997,12:439-446.
  • 7Vlassara H,Brownlee M,Manogub K,et al.Cachetin TNF and IL-1 induced by glucose-modifiad protein:role in normal tissues remodeling.Science,1998,240:1546-1548.
  • 8Blair HC,Schlesinger PH,Ross FP,et al,Recent advances toward understanding osteoclasts physiology.Clin Orthop,1993,294:7-22.
  • 9Blair HC,Kahn AJ,Grouch EC,et al.Isolated ostecclasts resorb the organic and inorganic components of bone.J Cell Biol,1986,102:1164-1172.
  • 10Takeshi M,Fumio A,Osamu O,et al.An adherent condition is required for formation of muhinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receotor activator of nuclear factor κB ligand.Blood,2000,96:4335-4343.

二级参考文献1

  • 1Antonio D. McCarthy,Susana B. Etcheverry,Liliana Bruzzone,Ana M. Cortizo. Effects of advanced glycation end-products on the proliferation and differentiation of osteoblast-like cells[J] 1997,Molecular and Cellular Biochemistry(1-2):43~51

共引文献12

同被引文献60

  • 1张大威,程岩,张金超,王乃利,杨梦甦,姚新生.淫羊藿苷对破骨细胞的分化及骨吸收功能的影响[J].中国药理学通报,2007,23(4):463-467. 被引量:73
  • 2Maeda SS, Lazaretti-Castro M. An overview on the treatment of postmenopausal osteoporosis. Arq Bras Endocrinol Metabol. 2014;58(2):162-171.
  • 3Costa AG, Cusano NE, Silva BC, et al. Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis. Nat Rev Rheumatol. 2011 ;7(8):447-456.
  • 4Kwak HB, Kim JY, Kim K J, et al. Risedronate directly inhibits osteoclast differentiation and inflammatory bone loss. Biol Pharm Bull. 2009;32(7):1193-1198.
  • 5Pang M, Martinez AF, Fernandez I, et al. AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells. Gene. 2004(1-2): 151-158.
  • 6Arai M, Nagasawa T, Koshihara Y, et al. Effects of beta-adrenergic agonists on bone-resorbing activity in human osteoclast-like cells. Biochem Biophys Acta. 2003;1640: 137-142.
  • 7Leung P, Pickarski M, Zhuo Y, et al. The effects Of the cethepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking. Bone. 2011 ;49(4):623-635.
  • 8Troen BR. The regulation of cathepsin K gene expression. Ann N YAcad Sci. 2006,1068:165-172.
  • 9Li Z, Hou WS, Escalante-Torres CR, et al. Collagenase activity of cathepsin k depends on complex fromation with chordroitin sulfate. J Biol Chem. 2002:277:28669-28876.
  • 10Wilson SR, Peters C,Saftig P, et aI.Cathepsin K Activity-dependent Regulation of Osteoclast Actin Ring Formation and Bone Resorption. J Biol Chem. 2009;284(4): 2584-2592.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部